Everything below concerns c-Met. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-10. Numbers and descriptions here follow the published literature rather than marketing material.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
| Property | Value | Notes |
|---|---|---|
| Molecular target | HGF/c-Met pathway | Proposed, not fully confirmed |
| Research models | Rodent cognition assays | Results vary by study |
| Human trial data | Limited or absent | No approved clinical use |
| Metabolic stability | Uncertain | Peptide degradation possible |
| Blood-brain barrier | Under investigation | Lipophilicity may affect distribution |
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
==== Pain circuitry ==== The outcome of NOP activation on the brain's pain circuitry is site-specific. Within the central nervous system its action can be either similar or opposite to those of opioids depending on their location. In animal models, activation of NOP in the brain stem and higher brain regions has mixed action, resulting in overall anti-opioid activity. NOP activation at the spinal cord and peripheral nervous system results in morphine-comparable analgesia in non-human primates.
== Symmetry == During the 19th century crystallography was progressively transformed into an empirical and mathematical science by the adoption of symmetry concepts. In 1832 Franz Ernst Neumann used symmetry considerations when studying double refraction in crystals. Woldemar Voigt, who was a student of Neumann, in 1885 formalized Neumann's principle as "if a crystal is invariant with respect to certain symmetry operations, any of its physical properties must also be invariant with respect to the same symmetry operations". Neumann's principle is sometimes referred to as the Neumann–Minnigerode–Curie principle based on later work by Bernhard Minnigerode (another student of Neumann) and Pierre Curie. Curie's principle "the symmetries of the causes are to be found in the effects" is a generalization of Neumann's principle. The relations between symmetry and physical and chemical properties were established throughout the 19th century: the notion of hemihedry (Weiss, 1819; Delafosse, 1840), the 7 crystal systems (Mohs, 1822), the notion of point lattice (Seeber, 1824), the 32 crystal classes (Frankenheim, 1826; Hessel, 1830; Gadolin, 1869), molecular chirality (Pasteur, 1848), the 14 Bravais lattices (Bravais, 1850), the 65 chiral groups that contain only proper symmetry operations – rotations, translations and roto-translations (Sohncke 1879), and, finally, the 230 space groups (Fedorov, 1891; Schoenflies, 1891; Barlow, 1894).
The DNA double helix is stabilized primarily by two forces: hydrogen bonds between nucleotides and base-stacking interactions among aromatic nucleobases. The four bases found in DNA are adenine (A), cytosine (C), guanine (G) and thymine (T). These four bases are attached to the sugar-phosphate to form the complete nucleotide, as shown for adenosine monophosphate. Adenine pairs with thymine and guanine pairs with cytosine, forming A-T and G-C base pairs.
Massive spying by the US on many countries, revealed by Edward Snowden. After the NSA's spying on Germany's Chancellor Angela Merkel was revealed, the Chancellor compared the NSA with the Stasi. The NSA recording nearly every cell phone conversation in the Bahamas, without the Bahamian government's permission, and similar programs in Kenya, the Philippines, Mexico and Afghanistan. The "Titan Rain" probes of American defense contractors computer systems since 2003. The Office of Personnel Management data breach, in the US, widely attributed to China. The security firm Area 1 published details of a breach that compromised one of the European Union's diplomatic communication channels for three years.
Worldwide about one billion people are estimated to be iodine-deficient; however, it is unknown how often this results in hypothyroidism. In the United States, overt hypothyroidism occurs in approximately 0.3–0.4% of people. Subclinical hypothyroidism, a milder form of hypothyroidism characterized by normal thyroxine levels and an elevated TSH level, is thought to occur in 4.3–8.5% of people in the United States. Hypothyroidism is more common in women than in men. People over the age of 60 are more commonly affected. Dogs are also known to develop hypothyroidism, as are cats and horses, albeit more rarely. The word hypothyroidism is from the Greek hypo- ('reduced'), thyreos ('shield'), and eidos ('form'), whereby the two latter parts refer to the thyroid gland.
Sources: en.wikipedia.org
Completed in 2016, Cat Dreams is Ned Lagin's first music CD, and first public music, since 1975. Cat Dreams is formally a suite of composed pieces, and composed melodic, tonal, and rhythmic frameworks for improvisation. These are presented as solo, duo, small group, and band; acoustic, electric, electronic music. Originally composed and planned for a two CD release, Cat Dreams is the first of the two CDs that comprise the full suite of compositions. On Cat Dreams, Lagin plays electric piano, keyboard synths (including vocals, cello, acoustic guitar, electric guitar, pedal steel guitar, banjo, and others), Native American flutes, and softsynths: Ableton Live and Max for Live, Reason, Reaktor The other musicians performing on Cat Dreams:
=== North American supply === As the war intensified with German air raids on the UK, Florey and Ethel decided to send their children away to a safer country in July 1940. The United States was not yet at war, and John Fulton, the Sterling Professor of Physiology at Yale University, and his wife Lucia agreed to care for them at their home in New Haven, Connecticut, "for the duration". In April 1941, the Rockefeller Foundation's Warren Weaver met with Florey, and they discussed the difficulty of producing sufficient penicillin to conduct clinical trials. Weaver arranged for the foundation to fund a three-month visit to the United States for Florey and a colleague so they could explore the possibility of the production of penicillin there. Since his aim was to persuade a firm to manufacture penicillin, and Heatley knew the most about penicillin production, Florey chose to take Heatley with him, and did not tell Chain until the morning of their departure. Chain, who saw penicillin as a joint project between himself and Florey, with Heatley as a laboratory technician, was greatly offended. Chain later wrote: "I left the room silently but shattered by the experience of this underhand trick and act of bad faith, the worst so far in my experience of Florey. It spoiled my initially good relations with this man for ever." Florey and Heatley left by air from Lisbon for the United States on 27 June 1941. In New Haven Florey met Fulton and was reunited with his children.
Altria, like other tobacco companies, has invested in science and medical companies which develop and produce medical products for conditions caused or aggravated by smoking. As of 2024, Altria's three medical subsidiaries included the following: Cronos group (maker of recreational cannabis), Lexaria Bioscience (Developer of proprietary drug delivery technology, DehydraTECH, to improve active pharmaceutical ingredients entrance into the bloodstream) and Micreos (biotech company focused on discovering and developing recombinant proteins for chronic dermatology and oncology conditions). It has also designed and marketed electronic cigarettes. Altria launched the MarkTen and Green Smoke brands. Both of these were discontinued in December 2018. The company returned to this market through the acquisition of NJOY.
The phosphate groups of DNA give it similar acidic properties to phosphoric acid and it can be considered as a strong acid. It will be fully ionized at a normal cellular pH, releasing protons which leave behind negative charges on the phosphate groups. These negative charges protect DNA from breakdown by hydrolysis by repelling nucleophiles which could hydrolyze it. Pure DNA extracted from cells forms white, stringy clumps.
=== Availability === Midazolam is available in the United States as a syrup or as an injectable solution. Dormicum brand midazolam is marketed by Roche as white, oval, 7.5 mg tablets in boxes of two or three blister strips of 10 tablets, and as blue, oval, 15 mg tablets in boxes of two (Dormonid 3x) blister strips of 10 tablets. The tablets are imprinted with "Roche" on one side and the dose of the tablet on the other side. Dormicum is also available as 1, 3, and 10 mL ampoules at a concentration of 5 mg/mL. Another manufacturer, Novell Pharmaceutical Laboratories, makes it available as Miloz in 3 and 5 mL ampoules. Midazolam is the only water-soluble benzodiazepine available. Another maker is Roxane Laboratories; the product in an oral solution, midazolam HCl Syrup, 2 mg/mL clear, in a red to purplish-red syrup, cherry in flavor. It becomes soluble when the injectable solution is buffered to a pH of 2.9–3.7. Midazolam is also available in liquid form. It can be administered intramuscularly, intravenously, intrathecally, intranasally, buccally, or orally.
Sources: en.wikipedia.org
== First Ministry == On 16 February 1993, the Governor, Sir Francis Burt, designated 17 principal executive offices of the Government under section 43(2) of the Constitution Acts Amendment Act 1899. The following ministers were then appointed to the positions, and served until the reconstitution of the Ministry on 10 February 1995. The list below is ordered by decreasing seniority within the Cabinet, as indicated by the Government Gazette and the Hansard index. Blue entries indicate members of the Liberal Party, whilst green entries indicate members of the National Party.
In April 2019, the Minister of Public Works announced that a list of potential sites had been drawn up. In 2020, it was suggested that moving parliament to Pretoria would save R650 million per year. In January 2022, a fire broke out at the Houses of Parliament building in Cape Town causing severe damage to the session rooms of both the National Council of Provinces and the National Assembly. The 2022 State of the Nation Address was held at Cape Town City Hall and subsequent meetings of the National Assembly will be held at the Good Hope Chamber. The Good Hope Chamber has previously been used for committee meetings of the National Assembly and has a seating capacity of 170, reduced to 70 during COVID-19 precautions. The National Assembly has 400 members. Subsequently, to enable a more permanent venue during the rebuild of the Houses of Parliament, Minister of Public Works and Infrastructure Dean Macpherson oversaw major enhancements of the existing Nieuwmeester Dome, which were installed to suit Parliamentary sittings. The dome was built over a parking lot in Roeland Street, close to the Houses of Parliament. It served as the site of the 2026 State of the Nation debates. In February 2026, Secretary to Parliament Xolile George announced that the Parliamentary rebuild would be completed in December 2026.
In the distal ileum, 95% of these conjugated BAs are actively reabsorbed via ASBT but 5% enter the colon and are converted by gut microbes into deconjugated secondary bile acids, predominantly deoxycholic acid (DCA) and lithocholic acid (LCA). DCA and LCA are then reabsorbed into portal circulation and reach the liver, where they serve as signaling molecules that maintain bile acid homeostasis. Specifically, DCA and LCA and potent agonists of farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5), both of which mediate anti-inflammatory and cholangioprotective effects upon activation. On cholangiocytes, TGR5 activation induces CFTR to secrete chloride into bile ducts, which then drives anion exchanger 2 to secrete bicarbonate into bile canaliculi. Bicarbonate serves to protect the apical surface of cholangiocytes from damage by bile acids. On macrophages, activation of FXR and TGR5 inhibits NF-κB, thereby reducing production of proinflammatory cytokines. Therefore, it is hypothesized that a reduction in secondary bile acid production, as a result of dysbiosis, could lead to bile duct damage via decreased activation of FXR and TGR5. Indeed, lower levels of secondary bile acids were found in PSC patients, but a causal relationship is yet to be confirmed.
Moscow's architecture is internationally known. Moscow is the site of Saint Basil's Cathedral—with its onion domes—as well as the Cathedral of Christ the Saviour and the Seven Sisters (Stalin-era skyscrapers). The first Kremlin was built in the middle of the 12th century. Medieval Moscow's design featured concentric walls and intersecting radial thoroughfares. That layout, as well as the city's rivers, helped to shape the city's design in later centuries. The Kremlin was rebuilt during the 15th century. Its towers and some of its churches were built by Italian architects, lending the city some atmosphere of the Renaissance period. From the end of the 15th century, Moscow was embellished by masonry structures such as monasteries, palaces, walls, towers, and churches. The city's appearance had not changed much by the 18th century. Houses were constructed of pine and spruce logs; they had shingled roofs plastered with sod or covered by birch bark. The rebuilding of Moscow during the second half of the 18th century was motivated by continual fires and the needs of the nobility. Much of the old wooden city was replaced by buildings in the classical style. For much of its history, Moscow's architecture was dominated by Orthodox churches. However, the city's overall appearance changed during Soviet times, especially as a result of Joseph Stalin's large-scale effort to "modernize" Moscow.
Sources: en.wikipedia.org
It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.
Published human trials are lacking. Most data come from cell cultures and animal models. Therefore, clinical effects and safety in people are uncertain.
It has been promoted in online communities for cognitive enhancement. That discussion is based largely on preclinical findings. It does not constitute evidence of efficacy or safety.
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.